Microglial activation and dopaminergic cell injury: An in vitro model relevant to Parkinson's disease

Journal of Neuroscience

Volumn 21, Issue 21, 2001, Pages 8447-8455

  Le, Wei Dong ^a   Rowe, Dominic ^a   Xie, Wenjie ^a   Ortiz, Irving ^a   He, Yi ^a   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DAergic neurons; IgG; Inflammatory; Microgfia; Oxidative stress; Parkinson's disease

Indexed keywords

1,4 BENZOQUINONE; DOPA; FC RECEPTOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CYTOKINE RELEASE; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; EMBRYO; INFLAMMATION; MICROGLIA; MOUSE; NERVE CELL LESION; NERVE CELL MEMBRANE CONDUCTANCE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0035503074     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-21-08447.2001     Document Type: Article

References (50)

1. Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs
2. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis
3. Inhibition of tyrosine hydroxylase expression within the substantia nigra of mice infected with canine distemper virus
4. 2 forming NADPH oxidase in microglia, monocytes, and neurotrophis
5. Improving the survival of grafted dopaminergic neurons: A review over current approaches
6. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system
7. Activated microglia mediate neuronal cell injury via nitric oxide mechanism
8. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins
9. A novel N18TG2 mesencephalon cell hybrid expresses properties which suggest a dopaminergic cell line of substantia nigra origin
10. Increase levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
11. Pathology of Parkinson's disease
12. Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: A mechanism for bystander demyelination
13. Glia cells and inflammation in Parkinson's disease: A role in neurodegeneration
14. FceRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
15. Fc receptor-bearing accessory cells in humoral immunity
16. Understanding cell death in Parkinson's disease
17. Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines
18. Microglia: A sensor for pathological events in the CNS
19. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
20. Heterogeneity in the distribution and morphology of microglia in the normal mouse brain
21. Protective effects of IGF-1, b-FGF, EGF, NGF, and cAMP on oxidation and hypoglycemia-induced damage in hybrid dopaminergic cells
22. Experimental autoimmune nigral damage in guinea pigs
23. Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: The role of nitric oxide and NMDA-gated channel activation leading to apoptosis
24. Immune invasion with serum against DA neurons induces a Parkinsonian model in rats
25. Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells
26. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
27. Antineuronal antibodies and markers of immune system activation in Parkinson's disease
28. Therapeutic implications of microglia activation by lipopolysaccharide and reactive oxygen species generation in septic shock and central nervous system pathologies: A review
29. Rate of cell death in parkinsonism indicates active neuropathological process
30. Reactive microglia are positive for HLA-DA in the substantia nigra of Parkinson's and Alzheimer's disease brain
31. Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures
32. Altered glia function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures
33. Cytokines in inflammatory brain lesions: Helpful and harmful
34. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
35. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
36. Covalent cross-linking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation
37. Neuronal control of immune response in the central nervous system: Linking brain immunity to neurodegeneration
38. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: Implications for pathogenesis
39. A rat model of Parkinson's disease induced by Japanese encephalitis virus
40. Neurodegeneration and Parkinson's disease
41. Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus
42. Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation
43. Mitochondrial complex I deficiency in Parkinson's disease
44. Serum antibodies to skeletal muscle-derived L-type calcium channels in patients with amyotrophic lateral sclerosis
45. FcR γ chain deletion results in pleiotropic effector cell defects
46. FcRγ-chain is essential for both surface expression and function of human FcγRI (CD64) in vivo
47. In vitro cell cultures as a model of the basal forebrain
48. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
49. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
50. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons